Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

(5) Goodwill and Intangible Assets

Goodwill:

All goodwill reported at March 31, 2024 and December 31, 2023 is allocated to our Healthcare Solutions reportable segment. The change in the goodwill balance between December 31, 2023 and March 31, 2024 reflects the impact of changes in foreign exchange rates on the portion of our goodwill balance that is recorded in currencies other that the U.S. dollar in the financial statements of foreign subsidiaries.

Intangible Assets:

At March 31, 2024 and December 31, 2023, the Company's intangible assets, all of which have finite lives, were as follows:


	March 31, 2024						December 31, 2023
(in thousands)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets with finite lives:
Customer relationships	$	51,971	$	(50,393)	$	1,578	$	54,565	$	(52,796)	$	1,769
Acquired technology	46,754		(14,041)		32,713		47,515		(13,268)		34,247
Trade names	26,493		(14,257)		12,236		26,938		(14,059)		12,879
Patent costs	19,537		(11,355)		8,182		19,579		(11,350)		8,229

Acquired patents	16,444		(14,820)		1,624		16,503		(14,822)		1,681
Other	9,686		(5,901)		3,785		13,711		(9,792)		3,919
Total intangible assets	$	170,885	$	(110,767)	$	60,118	$	178,811	$	(116,087)	$	62,724

Amortization expense related to intangible assets was $1,996 and $3,239 for the three months ended March 31, 2024 and 2023, respectively. Amortization expense for intangible assets is estimated to be $6,019 for the remainder of 2024, $8,017 in 2025, $7,990 in 2026, $7,119 in 2027 and $6,663 in 2028.